Cargando…

CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis

OBJECTIVE: Proton pump inhibitors (PPIs) are an effective treatment for eosinophilic esophagitis (EoE); however, only 30% to 60% of patients respond. Common genetic variants in CYP2C19 and STAT6 associate with PPI plasma concentration and magnitude of inflammatory response, respectively. Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mougey, Edward B., Williams, Andre, Coyne, Ashlan J. Kunz, Gutiérrez-Junquera, Carolina, Fernández-Fernández, Sonia, Cilleruelo, Maria Luz, Rayo, Ana, Echeverría, Luis, Román, Enriqueta, González Lois, Carmen, Chao, Montserrat, Al-Atrash, Hadeel, Lima, John J., Franciosi, James P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Article: Gastroenterology: Eosinophilic GI Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855320/ https://www.ncbi.nlm.nih.gov/pubmed/31490856 http://dx.doi.org/10.1097/MPG.0000000000002480

Ejemplares similares

Proton-pump Inhibitor Response Prediction Using Esophageal microRNAs in Children With Eosinophilic Esophagitis
por: Cañas, José Antonio, et al.
Publicado: (2020)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
por: Gutiérrez-Junquera, Carolina, et al.
Publicado: (2018)

Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis
por: Mukkada, Vincent A., et al.
Publicado: (2023)

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
por: Gupta, Sandeep K., et al.
Publicado: (2022)

Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions
por: Franciosi, James P, et al.
Publicado: (2022)

Functional Changes in Acute Eosinophilic Myocarditis Due to Chemotherapy With Ibrutinib
por: Isaza, Nicolas, et al.
Publicado: (2019)

Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients
por: Warners, M. J., et al.
Publicado: (2017)

A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
por: Chey, William D, et al.
Publicado: (2011)

Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea
por: Pattni, Sanjeev S, et al.
Publicado: (2012)

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014)

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome
por: Marquis, P, et al.
Publicado: (2014)

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
por: Rao, Satish, et al.
Publicado: (2012)

The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study
por: Riddle, Mark S, et al.
Publicado: (2016)

Association Between the Location of Diverticular Disease and the Irritable Bowel Syndrome: A Multicenter Study in Japan
por: Yamada, Eiji, et al.
Publicado: (2014)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
por: Heidelbaugh, Joel J, et al.
Publicado: (2015)

The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment?
por: Y Lee, Chooi
Publicado: (2013)

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Schoenfeld, Philip, et al.
Publicado: (2018)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI
por: Lam, Ching, et al.
Publicado: (2017)

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
por: Miner Jr, Philip B, et al.
Publicado: (2017)

Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
por: Rezaie, Ali, et al.
Publicado: (2017)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome
por: Sayuk, Gregory S, et al.
Publicado: (2017)

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
por: Lacy, Brian E, et al.
Publicado: (2017)

Eosinophilic Esophagitis and Gastroesophageal Reflux Disease: An Overlapping of Clinical, Endoscopic and Manometric Features
por: Karapiperis, Dimitrios, et al.
Publicado: (2021)

Eosinophilic Esophagitis in a 75-Year-Old Saudi Man: A Case Report
por: Alkhowaiter, Saad S
Publicado: (2023)

Medical treatment of eosinophilic esophagitis
por: Franciosi, James P, et al.
Publicado: (2023)

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
por: Arechederra, Maria, et al.
Publicado: (2022)

Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in the Qassim Region, Saudi Arabia
por: Almuzaini, Reema, et al.
Publicado: (2023)

The Visible Stomach: Elusive Diffuse-Type Adenocarcinoma Presents With Gastric Outlet Obstruction
por: Safadi, Mhd F, et al.
Publicado: (2022)

The Effect of Proton Pump Inhibitor Use on Survival of Patients With Colorectal Cancer: A Study of a Racially Diverse Population
por: Obeidat, Adham E, et al.
Publicado: (2023)

Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications
por: Meyer, Johanna C, et al.
Publicado: (2022)

Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis
por: Peignon, Grégory, et al.
Publicado: (2011)

Recent advances in intestinal imaging
por: Sinha, Rakesh
Publicado: (2011)

CT features, mimics and atypical presentations of gastrointestinal stromal tumor (GIST)
por: Sripathi, Smiti, et al.
Publicado: (2011)

β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis
por: van Veelen, Wendy, et al.
Publicado: (2011)

Gastrointestinal Image: A True Giant Transverse Colon Diverticulum
por: Olakowski, Marek, et al.
Publicado: (2011)

Inverted Meckel’s Diverticulum with Ectopic Pancreatic Tissue as a Source of Severe Gastrointestinal Bleeding
por: Kopáčová, Marcela, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gbcnkcgqo1f5h14t2mkussviu4